NZ743587B2 - Methods and systems for providing stimuli to the brain - Google Patents
Methods and systems for providing stimuli to the brain Download PDFInfo
- Publication number
- NZ743587B2 NZ743587B2 NZ743587A NZ74358716A NZ743587B2 NZ 743587 B2 NZ743587 B2 NZ 743587B2 NZ 743587 A NZ743587 A NZ 743587A NZ 74358716 A NZ74358716 A NZ 74358716A NZ 743587 B2 NZ743587 B2 NZ 743587B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- auditory
- stimulus pattern
- user
- pattern
- stimulus
- Prior art date
Links
- 210000004556 Brain Anatomy 0.000 title claims description 15
- 230000000007 visual effect Effects 0.000 claims abstract description 46
- 210000000988 Bone and Bones Anatomy 0.000 claims abstract description 11
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 10
- 230000000638 stimulation Effects 0.000 claims description 44
- 230000001225 therapeutic Effects 0.000 claims description 30
- 210000003128 Head Anatomy 0.000 claims description 22
- 230000001953 sensory Effects 0.000 claims description 18
- 201000008839 post-traumatic stress disease Diseases 0.000 claims description 11
- 230000003340 mental Effects 0.000 claims description 7
- 230000000926 neurological Effects 0.000 claims description 6
- 206010022437 Insomnia Diseases 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 5
- 229940035295 Ting Drugs 0.000 claims 1
- 208000009025 Nervous System Disease Diseases 0.000 abstract description 6
- 206010029305 Neurological disorder Diseases 0.000 abstract description 6
- 206010070976 Craniocerebral injury Diseases 0.000 description 10
- 208000005765 Traumatic Brain Injury Diseases 0.000 description 10
- 239000003814 drug Substances 0.000 description 5
- 208000001183 Brain Injury Diseases 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000001965 increased Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000001360 synchronised Effects 0.000 description 3
- 206010002855 Anxiety Diseases 0.000 description 2
- 206010057666 Anxiety disease Diseases 0.000 description 2
- 206010016754 Flashback Diseases 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 206010034721 Personality disease Diseases 0.000 description 2
- 206010061920 Psychotic disease Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 238000004883 computer application Methods 0.000 description 2
- 235000014632 disordered eating Nutrition 0.000 description 2
- 201000006180 eating disease Diseases 0.000 description 2
- 230000002045 lasting Effects 0.000 description 2
- 230000015654 memory Effects 0.000 description 2
- 201000008895 mood disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010049848 Balance disease Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 229960003987 Melatonin Drugs 0.000 description 1
- 206010052639 Nerve injury Diseases 0.000 description 1
- 210000003625 Skull Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010009740 Vp16-Jazz protein Proteins 0.000 description 1
- ZAFYATHCZYHLPB-UHFFFAOYSA-N Zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 230000001149 cognitive Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 230000000792 effect on seizure Effects 0.000 description 1
- 230000001037 epileptic Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 230000000051 modifying Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001702 transmitter Effects 0.000 description 1
- 230000000472 traumatic Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 229960001475 zolpidem Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
- A61M2021/005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense images, e.g. video
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/507—Head Mounted Displays [HMD]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/088—Supports for equipment on the body
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/01—Head-up displays
- G02B27/017—Head mounted
Abstract
Visual and auditory stimuli are provided to a patient to treat various neurological disorders or conditions. The visual and auditory stimuli are provided by a wearable headset or sleep mask that may be comfortably worn by a user, such as in bed to induce sleep. The wearable headset or sleep mask is operated by a personal computing device of the user, such as smartphone, having downloaded and active thereon a control application or app for the therapy. The wearable headset or sleep mask also concurrently provides tactile stimuli, and the tactile stimulus is provided from bone conduction transducers that concurrently provides the auditory stimuli. operated by a personal computing device of the user, such as smartphone, having downloaded and active thereon a control application or app for the therapy. The wearable headset or sleep mask also concurrently provides tactile stimuli, and the tactile stimulus is provided from bone conduction transducers that concurrently provides the auditory stimuli.
Description
S AND SYSTEMS FOR ING STIMULI TO THE BRAIN
CAL FIELD
The present disclosure relates to medical devices and methods. In particular, the
present disclosure relates to providing stimuli to a subject to treat various neurological disorders
or conditions and/or to provide performance enhancement.
BACKGROUND ART
Sensory stimulation has been applied to treat various disorders. For example, binaural
beats have d to induce various mental states to encourage sleep, relaxation, meditation,
creativity, and other desirable mental . Combinations of auditory and visual stimuli have
been applied to age such mental states as well. The application of such therapy, however,
has been less than ideal in many circumstances. Equipment to e the stimulus can be bulky,
expensive, generally inaccessible, and below the critical efficacy threshold for widespread use,
typically only helping subsets of the population. Users may find the use of such equipment
difficult in many stances, such as when trying to sleep in a bedroom or an ne cabin.
To treat various neurological disorders and conditions, pharmaceuticals and/or
supplements are often used instead of sensory stimulation. The use of pharmaceuticals, r,
can be less than ideal in many circumstances. Often, pharmaceuticals are expensive, rely on
patient-compliance, and may require a prescription from a medical professional. Pharmaceuticals
may be effective in only a small, less than ideal portion of the general population. To treat
insomnia, for example, pharmaceuticals and supplements such as melatonin and Zolpidem (e.g.,
AmbienTM) have questionable efficacy. ceuticals often lead to undesirable side effects.
For example, some pharmaceutical for treating insomnia can lead to deprivation in certain ranges
of deep sleep and increases in mortality rates.
For at least these reasons, improved methods and s to treat neurological
disorders and other conditions that me at least some of the entioned challenges are
desired.
DISCLOSURE OF INVENTION
The present disclosure relates to medical devices and methods which may be used, for
example, to provide stimulus to a subject to treat various neurological disorders or conditions,
where the stimulus provided may include one or more of an auditory, a visual, or a tactile
us. Examples of ogical disorders which may be treated with devices and methods
may include, but are not limited to, insomnia, post-traumatic stress disorder (PTSD), brain
injuries including, but not d to traumatic brain injury (TBI), mild traumatic brain injury
(mTBI), or injury from oxygen deprivation of the brain from strokes, depression, anxiety, mood
disorders, personality disorders, eating disorders, psychotic disorders, and balance disorders, to
name a few. atively or in combination, the stimulus provided by the medical devices and
methods described herein may provide cognitive benefits and/or enhancement, ing, but not
limited to, improving neuroplasticity, motor skills, nation, reaction times, alertness,
energy, working memory, mood, and feelings of wellbeing.
In certain embodiments, stimuli may be ed to the wearer of a t or sleep
mask that may be comfortably worn by a user, such as in bed to induce sleep. The wearable
headset or sleep mask may be operated by a personal computing device of the user, such as
smartphone, having downloaded and active thereon a control application or “app” for the
therapy. The wearable headset or sleep mask may also concurrently provide e i, and
the tactile stimuli may be provided from bone conduction transducer that may concurrently
provide the auditory stimuli. Various patterns of the stimuli to induce ent user responses are
also disclosed.
In certain embodiments, a device is provided that produces an output that may be
perceived by a user of the device as a visual, auditory or tactile stimuli at one or more
frequencies, or in one or more frequency ranges. In certain ments, the stimuli may be
turned on and off at frequencies that are believed to induce one or more frequencies of electrical
activity in the brain, which are generally accepted as being delta waves (1.0 to 3.0 Hz), theta
waves (30 to 7.0 Hz), alpha waves (7 .0 to 12 Hz), beta waves (12 to 38 Hz), and gamma waves
(38 to 42 Hz).
Thus, for example, one embodiment device es an output that may be perceived
by a user of the device as a stimuli at sequential frequencies, such as sequences of alpha waves,
theta waves, and delta waves. In certain embodiments, the stimuli is a coordinated auditory and
visual stimulation, providing right and left eyes and ears to pulsed light and pulsed auditory in
each of the ranges listed above. As one example, the coordinated stimulation may be: 1) both
eyes and both ears being stimulated at the same time; 2) the left eye and ear being ated at
the same time, followed by the right eye and ear being stimulated at the same time; 3) both eyes
being stimulated at the same time, followed by both ears being stimulated at the same time; or 4)
the right eye and left ear being stimulated at the same time, followed by the left eye and right eye
being stimulated at the same time. In each case, the ation may include, for example,
sequentially stimulating in the alpha wave range, followed by the theta wave range, ed by
the delta wave range. The stimulation can last for a period of one minute up to an hour.
It is one aspect to e a method to provide ation to a user. The method
includes: providing a headset to be worn by the user; ng, with the headset, a left visual
stimulus pattern to the left eye of the user; applying, with the headset, a right visual stimulus
pattern to the right eye of the user; applying, with the headset, a left auditory stimulus pattern to
the left side of a head of the user; and applying, with the headset, a right auditory stimulus pattern
to the right side of the head. The applications of the left visual stimulus pattern, the right visual
stimulus pattern, the left auditory stimulus pattern, and the right auditory stimulus pattern are
coordinated with one another.
It is another aspect to provide a method of treating a neurological disease or condition
or providing performance enhancement using the method of ing stimulation to a user. The
method includes: providing a headset to be worn by the user; applying, with the headset, a left
visual stimulus pattern to the left eye of the user; applying, with the headset, a right visual
us pattern to the right eye of the user; applying, with the headset, a left ry stimulus
pattern to the left side of a head of the user; and applying, with the headset, a right auditory
stimulus pattern to the right side of the head. The applications of the left visual stimulus pattern,
the right visual stimulus pattern, the left auditory stimulus pattern, and the right auditory stimulus
pattern are coordinated with one another.
It is one aspect to provide an apparatus to provide ation to a user. The apparatus
includes: a frame configured to be worn on a head of a user; a left light source configured to
generate a left visual stimulus pattern; a right light source configured to generate a right visual
stimulus pattern; a left auditory source configured to generate a left auditory stimulus pattern; a
right auditory source configured to generate a right auditory stimulus n; and a ller
coupled to the left light source, the right light source, the left auditory , and the right
auditory , The applications of the left visual stimulus pattern, the right visual stimulus
pattern, the left auditory stimulus pattern, and the right auditory stimulus pattern are
independently controlled from one another but coordinated with one another by the controller.
It is yet another aspect to provide a method to provide stimulation to a user, the
method includes: concurrently providing a left-side light us to a left eye of the user, a right-
side light stimulus to a right eye of the user, a left-side ry stimulus to a left side of the user,
and a right-side ry stimulus to a right side of the user for a first time interval; alternating
providing the left-side light stimulus and left-side ry stimulus with providing the right-side
light stimulus and right-side auditory stimulus for a second time interval; alternating providing
the left-side and right-side light stimuli with providing the ide and right-side auditory
stimuli for a third time interval; and alternating providing the left-side light stimulus and right-
side auditory stimulus with providing the right-side light stimulus and left-side auditory stimulus
for a fourth time interval.
It is one aspect to provide a method of treating a neurological disease or condition or
providing mance enhancement using the method of concurrently providing a left-side light
stimulus to a left eye of the user, a right-side light stimulus to a right eye of the user, a left-side
auditory stimulus to a left side of the user, and a right-side auditory stimulus to a right side of the
user for a first time interval; alternating providing the left-side light stimulus and left—side
auditory stimulus with providing the right-side light us and right-side auditory stimulus for
a second time interval; alternating providing the left—side and right-side light stimuli with
providing the left-side and right-side auditory stimuli for a third time al; and alternating
providing the left-side light us and right-side auditory stimulus with ing the right-
side light stimulus and left-side auditory stimulus for a fourth time al.
It is another aspect to e a method of providing stimulation to a user, The
method includes: providing a headset to be worn by the user; applying, with the headset, a left
auditory stimulus pattern to the left side of a head of the user; and applying, with the headset, a
right auditory stimulus pattern to the right side of the head, The applications of the left auditory
stimulus pattern and the right ry us pattern are coordinated with one r.
These features together with the various ancillary provisions and es which will
become apparent to those skilled in the art from the following detailed description, are attained
by the methods and system for providing stimulation to a user of the present ion,
embodiments thereof being shown with reference to the accompanying gs, by way of
example only, wherein:
BRIEF DESCRIPTION OF DRAWINGS
FIGS. 1A and 1B show schematic diagrams of therapeutic systems to provide
therapeutic auditory, visual, and/or tactile stimulus, according to many embodiments of the
present disclosure;
FIGS. 2A and 2B show schematic diagrams of the controller for the therapeutic
systems of FIGS. 1A and 1B;
shows an exemplary therapeutic wearable headset or sleep mask, according
to many embodiments;
shows a user wearing the therapeutic wearable headset and sleep mask of
; and
shows a flow chart of a therapeutic method of providing therapeutic auditory,
visual, and/or tactile us, according to several embodiments.
MODES FOR NG OUT THE INVENTION
FIGURE 1A is a schematic diagram of a first ment therapeutic system 100.
Therapeutic system 100 provides one or more outputs that a person wearing the therapeutic
system may ence as auditory, , and/or e stimulus. Thus, in one embodiment,
therapeutic system may comprise a left light source 110L, a right light source 110R, a left
vibration source 120L, a right vibration source 120R, and a controller 130 for independently
controlling and coordinating the action of the light and vibration sources. Thus, for example,
therapeutic system 100 may be positioned on the head of a user with left light source 110L
positioned over the left eye to provide a left visual stimuli, right light source 110R positioned
over the right eye to provide a right visual stimuli, left vibration source 120L positioned to
provide left ear auditory stimuli, and right Vibration source 120R positioned to provide right ear
auditory stimuli.
In one embodiment, left and right light sources 110L, 110R may each comprise light-
ng diodes, an incandescent light source having a wavelength filter, a fluorescent light
source, a backlit LCD panel, or other light source configured to provide to the user light at a
desired, ermined wavelength or wavelength range.
In another embodiment, left and right ion sources 120L, 120R may each
comprise earbuds, miniature speakers, or other vibration sources that can provide auditory stimuli
to a user. In certain other embodiments, left and right vibration sources 120L, 120R may
comprise bone conduction transducers in the e frequency range to provide vibrations to the
user’s skull bone that is sensed as auditory by the user’s ear. Optionally, one or more of left and
right vibration sources 120L, 120R may also produce vibrations that are sensed as tactile stimuli.
Thus, for example, controller 130 may provide first signals to bone conduction transducers that
vibrate or oscillate at a first frequency that can be interpreted by the user as auditory stimuli and
may provide second signals at a second, lower frequency that can be reted as a tactile
sensation by the user. In other words, bone conduction transducers may be adapted to provide
both auditory and e stimulus to the user.
In n embodiments, left and right vibration sources 120L, 120R provide output at
specific one or more frequencies or a range of frequencies, and are turned on and off at a
stimulation frequency. Thus, for example, a vibration source may be programmed to provide an
output at an audio frequency of 256 Hz for some period of time, followed by no output for the
following period of time. Thus, the vibration source is the product of an audio frequency and a
square wave.
FIGURE 1B is a schematic m of a second ment therapeutic system 100’.
Second embodiment therapeutic system 100’ is generally similar to first embodiment therapeutic
system 100’, except as explicitly noted. Specifically, second ment therapeutic system
100’ includes a left tactile us source 121L and a right tactile stimulus source 121R, each of
which may be individually controlled and coordinated with the controller 130 to provide tactile
stimuli to a user of therapeutic system 100’.
FIGURES 2A and 2B show schematic diagrams of the controller 130 of therapeutic
system 100 or 100’. As shown in , eutic system 100 or 100’ may optionally
include an external l unit 13021 that may wirelessly communicate with a wireless
receiver/transmitter 130C of the ller 130 through a wireless connection 131a. The wireless
connection 131a may comprise a oth connection, a Bluetooth LE connection, a WiFi
connection, a ZigBee connection, an infrared (IR) connection, a radiofrequency (RF) tion,
or an inaudible auditory signal connection, to name a few examples. The external control unit
130a may comprise a custom-built, electronic controller. In many embodiments, the external
control unit 130a may comprise a al computing device of the user that may have
downloaded onto and operating, a custom computer application or “app” to operate the system
100 or 100’ to provide a therapeutic regimen. For example, the personal computing device may
comprise a personal computer, a personal laptop computer, a tablet computer (such as an Apple
iPad, a Samsung Galaxy Tab, a Microsoft Surface, or an Amazon Fire, to name a few examples),
a smartphone (such as an Apple iPhone, a Samsung Galaxy phone, or a Google Nexus phone, to
name a few examples), and the custom computer application or “app” may be an application or
“app” downloadable from an application distribution platform such as Apple iTunes, Apple
Store, Google Play, Google Chrome Web Store, Amazon App Store, or Microsoft Windows
Store, to name a few examples. The application may e one or more eutic regimens
that the user may select for implementation by the therapeutic system 100 or 100’. In some
embodiments, the application may allow the user to provide feedback information about the
efficacy of the therapeutic regimen(s), the feedback may be uploaded and collected by a central
server(s) in communication with the ation, and the eutic regimen(s) may be
improved or optimized based on the feedback from the one or more users. atively or in
combination, as shown in , the system 100 or 100’ may further comprise an external
control unit 130a, such as a custom-built controller, that may communicate with the controller
130 through a wired connection 13121, for example, a USB, FireWire, or Lightning connection, to
name a few examples.
FIGURE 3A shows one embodiment ofthe therapeutic system 100 as including
therapeutic wearable headset or sleep mask 140 which integrates the light, vibration, and,
optionally, tactile sources into a single form factor for presentation to a user. Thus, for example,
when a user places le headset or sleep mask 140 on their head, left light source 110L is
positioned over the left eye to provide a left visual stimuli, right light source 110R is positioned
over the right eye to provide a right visual stimuli, left vibration source 120L is positioned to
provide left ear auditory stimuli, and right vibration source 120R is positioned to provide right
ear auditory stimuli.
As discussed above and herein, the left vibration source 120L and the right ion
source 120R may each comprise bone conduction transducer that may provide both auditory and
tactile stimulus. Alternatively, wearable headset or sleep mask 140 is therapeutic system 100’
which includes left tactile stimulus source 121L and right tactile stimulus source 121R, each of
which may be dually controlled and coordinated with the controller 130, as described above
regarding .
As discussed above and herein, the therapeutic le headset or sleep mask 140
may be ed with an external controller 130a (e.g., a hone) in communication with the
controller 130 through a ss connection 131a, for example. The user US may have an option
to turn tactile stimulation on or off, for example. shows a user US wearing the
eutic le headset or sleep mask 140.
FIGURE 4 shows a flow chart of an exemplary therapeutic method 400 for providing
therapeutic auditory, visual, and/or tactile stimulus. In a step 410, a subject having a neurological
er or condition may be identified. Examples of neurological disorders may include, but are
not limited to, insomnia, post-traumatic stress disorder (PTSD), brain es such as traumatic
brain injury (TBI), mild traumatic brain injury (mTBI), or es to the brain due to oxygen
deprivation, such as strokes, depression, anxiety, mood disorders, personality disorders, eating
disorders, and psychotic disorders. Alternatively, a subject may be selected to undergo a
therapeutic method 400 for the purpose of performance enhancement of mental and/or physical
tasks for to aid the subject in napping or sleeping. In a step 420, the subject may be provided the
therapeutic system or headwear, such as the system 100 or 100’ described above. In a step 430,
the subject may wear the eutic system or headwear, such as wearable headset or sleep mask
140. In a step 440, headset 140 executes programming 450 provided in controller 130 to provide
stimuli to the subject. The programming es two or more of auditory, video, and/or tactile
stimulus are concurrently provided by headset 140 to the t, and thus, for e, may
provide power to activate left light source 110L, right light source 110R, left vibration source
120L and or right vibration source 120R.
As discussed above and herein, the left vibration source 120L and the right vibration
source 120R may each comprise bone conduction transducer that may provide both auditory and
tactile stimulus. atively, wearable headset or sleep mask 140 is therapeutic system 100’
which includes left tactile stimulus source 121L and right tactile stimulus source 121R, each of
which may be individually controlled and coordinated with the controller 130, as described above
regarding .
In n embodiments, providing two or more of auditory, video, and/or tactile
stimulus concurrently may provide improved therapeutic benefits as compared to providing only
one of auditory, video, or tactile us at one time. The two or more auditory, video, and/or
tactile stimulus may thus e to provide the improved eutic benefits, for example (i.e.,
the two or more auditory, video, and/or tactile stimulus may ize in a way to provide
improved results over providing two of the stimuli individually.)
Exemplary instructions for providing stimuli may be ed, for example, by
programming 450, such as a subroutine 450a, which includes the simultaneous activation of all
active auditory, video, and/or tactile stimulus sources. Optionally, the activation of all s
may include the activation of tactile stimulation to run throughout all subsequent auditory and/or
visual stimulation. Another exemplary subroutine 450b may comprise alternating the left
ry, video, and/or tactile stimulus sources with the right auditory, video, and/or tactile
us sources (i.e., the left stimuli and right stimuli take turns being active.) Another
exemplary subroutine 450C may comprise alternating the visual sources with the auditory and/or
tactile sources (i.e., the visual stimuli and the auditory/tactile stimuli take turns being active.)
r exemplary subroutine 450d may comprise alternating the left auditory and/or tactile
source and the right visual source with the right auditory and/or tactile source and the left visual
source (i.e., opposite auditory/tactile stimuli take turns being active.) Such programming is
r described below.
In step 440, programming 450, ing by not limited to subroutines 450a, 450b,
450C, and 450d, may each be applied one or more times, individually or in combination with one
another. The programming may, in addition, provide sequences of output in subroutines 450a,
450b, 450e, and 450d at different frequencies and/or timings. Thus for example the subroutines
may provide output at specific frequencies that change as the tine is repeated. Thus for
example, tine 450a may provide auditory output to vibration source 120R or 120L at a
frequency of 256 Hz that is turned on and off, that is it is pulsed, at a pulse ncy of 1 Hz for
2 minutes. This square pulse auditory signal thus generates signals at a frequency of 1 Hz in
addition to higher harmonics. At a uent time the output at 256 Hz is pulsed at twice the
previous pulse frequency for 2 minutes. In this manner, the auditory frequency of 256 Hz may be
modulated over a wide range, including frequencies corresponding to brain wave ncies.
In addition, by ng the output between left and right channels, the brain may be
stimulated in a way that it is forced to communicate n the left and right sides of the brain.
This forced communication, for example, can allow PTSD memories to be wired to both sides of
the brain, thereby stopping undesirable flashbacks.
Although the above steps show method 400 of treating a t in accordance with
embodiments, a person of ordinary skill in the art will recognize many variations based on the
teaching described herein. The steps may be completed in a different order. Steps may be added
or deleted. Some of the steps may comprise sub-steps. Many of the steps may be repeated as
often as beneficial to the treatment.
One or more of the steps of the method 400 may be performed with the circuitry as
described herein, for example, circuitry of the controller 130 or the external control unit 130a
such as one or more of a processor or logic circuitry such as a central processing unit (CPU) or a
programmable array logic for field mmable gate array. The circuitry may be programmed
to provide one or more of the steps of the method 400, and the program may comprise program
instructions stored on a computer readable memory or programmed steps of the logic try
such as the programmable array logic or the field mmable gate array, for example.
EXAMPLE I
The following describes an example of a stimulation pattern that has been found by
empirical studies to be effective for inducing sleep, including napping, increasing neuroplasticity,
treating brain injuries from strokes, TBI, or mTBI, improving balance, including improving fine
motor control and reaction times, and treating PTSD, to name a few indications.
Light and auditory stimulus at a first frequency may be provided for a first time
segment, then at a second lower frequency for a second time t, and then at a third lower
frequency for a third time segment. Each time segment may include one or more gments of
light and auditory stimulus, each sub-segment comprising one of the subroutines described
above, for example. The light and auditory stimulus may end after a pre—determined time period,
such as 20 minutes. The light and auditory stimulus may be ramped back up (i.e., ng from
the third frequency, then transitioning to the second ncy, and finally transitioning to the
third frequency), such as to wake the user. Alternatively or in combination, the light and auditory
stimulus may be maintained at the second frequency such as to maintain a sleep state of the user.
As described above, tactile us may be provided concurrently with the auditory stimulus.
The light may be provided at a wavelength of 580 nm and the auditory having a frequency of 256
Hz may be provided, or any of a number of auditory ncies or combinations thereof that the
subject can select as they wish.
Table 1 below describes an exemplary treatment regimen for this example. The
stimulation provided in Table 1 first cycles through a block of four Segment A outputs, then
cycles through a block of four Segment B s, then cycles through seven blocks of four
Segment C outputs, and lastly repeats the block of four Segment A outputs. For Segment A
outputs (A1, A2, A3, and A4), the auditory and light s cycle 115 or 116 times between
being on for 0.1277 seconds and then being off for 0.1277 seconds (that is, at a pulse frequency
of 3.9 Hz), followed by no output for 0.5 seconds. For t B s (B1, B2, B3 and B4),
the auditory and light outputs cycle 44 or 45 times between being on for 0.3333 seconds and then
being off for 0.3333 seconds (that is, at a pulse ncy of 1.5 Hz) followed by no output for
0.5 seconds. For Segment C outputs (C1, C2, C3 and C4), the auditory and light outputs cycle 14
or 15 times between being on for 1 second and then being off for 1 second (that is, a pulse
frequency of 0.5 Hz), followed by no output for 1 second. Segments A1, B1, and C1 pulse the
right and left sides of both the light and auditory together, with all outputs are synchronized to be
on or off at the same time, as provided by subroutine 450a. Segments A2, B2, and C2
synchronize the left side light and auditory output, and the right side light and ry output to
be opposite to one another, as provided by subroutine 450b. Segments A3, B3, and C3
synchronize both lights together to be opposite to both ry s, as provided by
subroutine 450C. Segments A4, B4, and C4 synchronize the right auditory and light to be
opposite to the left auditory and light outputs, as provided by subroutine 450d.
TABLE 1
Auditory ry . . .
ts A1-A4 for 120s _—_—
Segment Al (Light and Auditory On 0.1277s On 0.1277s On 0.1277s On 0.1277s
both sides pulse together)
Repeat 116 times, followed by Off 0. 1277s Off 0.1277s Off 0. 1277s Off 0.1277s
Segment A2 (light and auditory
on left side, alternating light and On 0.1277s Off 0.1277s On 0.1277s Off 0.1277s
auditory on Right).
Repeat “6 bmbs’ foubwed by Off 0.1277s On 0.1277s Off 0.1277s On 0.1277s
Segment A3 ( both lights
together, ating with both On 0.1277s On s Off 0.1277s Off 0.1277s
auditories together)
Repeat “5 bmbs> fbllb‘yed by Off 0.1277s Off s On 0.1277s On 0.1277s
Segment A4 (auditory left and
light right together, alternating On 0.1277s Off 0.1277s Off 0. 1277s On 0.1277s
auditory right and light left
together)
Repeat 115 times, followed by Off 0. 12775 On 0.1277s On 0.1277s Off 0.1277s
Sements B1-B4 for 120s _—_—
On 03333s On 0. 3333s On 0. 3333s On 0. 3333s
both sides pulse together)
Repeat 45 times, followed by 05 Off 0.33335 Off 0.3333s Off 0.3333s Off 0.33335
Segment B2 (light and auditory
on left side alternating light and On 0.33335 Off 0.33335 On 0.33335 Off 5
auditory on Right)
Repeat 44 bmbs’ fbllb‘yed by Off 033335 On 0,3333s Off 0,3333s On 0.33335
Segment B3 ( both lights
together, alternating with both On 0.3333s On 0.3333s Off 0.3333s Off s
auditories together)
iii)“ bmbs’ fbub‘yed by 0'5 Off 0.3333s Off 0.3333s On 0.3333s On 0.3333s
Segment B4 (auditory left and
light right together, ating On s Off 0.3333s Off 0.3333s On s
auditory right and light left
together)
Repeat 44 times, followed by 0.5 Off 0.3333s On 0.3333s On 0.3333s Off 0.3333s
Repeat the following Segments
C1-C4 7 times for a total of 14
minutes
Segmentm (LightandAudnory
both sides pulse together)
Repeat 15 times, fOHOWBd by 1 Off 1 sec Off 1 sec Off 1 sec Off 1 sec
on left side, alternating light and Off 1 sec Off 1 sec
auditory on Right)
Repeat 15 times, followed by 1 Off] sec Off1 sec
sec gap
t C3 ( both lights
together, alternating with both On 1 sec On 1 sec Off 1 sec Off 1 sec
auditories together)
Segment C4 ory left and
light right together, alternating On 1 sec Off 1 sec Off 1 sec On 1 sec
ry right and light left
together) Offl sec
Repeat 14 times, followed by 1
Se_ments A1-A4 for 120s ___—
Segment Al (Light and Auditory On 01277 On 01277 On 01277 On 0.1277
both sides pulse together)
0.5 sec gap
on left side, alternating light and On 0,1277 Off 0.1277 On 0.1277 Off 0.1277
auditory on Right)
05 sec :ao
together, alternating With both On 0.1277 On 0.1277 Off 0. 1277 Off 0.1277
auditories together)
light right together, alternating On 0.1277 Off 0.1277 Off 0. 1277 On 0.1277
ry right and light left
Repeat 115 times, followed by Off 0. 1277 On 0.1277 On 0.1277 Off 0.1277
0.5 sec gap
EXAMPLE 2
The following describes an example of a stimulation pattern that has been found by
empirical studies to be effective for inducing sleep. The stimulation pattern of Example 2
includes the part of the treatment regimen shown in Table 1. Specifically, the stimulation first
cycles through a block of four Segment A outputs, then cycles through a block of four Segment B
outputs, and then cycles through seven blocks of four Segment C outputs. The repetition of the
last block of four Segment A s is not provided in Example 2.
EXAMPLE 3
The following described example of a stimulation pattem that has been found by
empirical studies to be effective for increasing alpha wave brain activity, inducing
neuroplasticity, treating stroke or other brain injuries such as TBI, mTBI, including ing
balance, improving fine motor control and reaction times, and treating PTSD, to name a few
indications.
In this example, the four subroutines described above and herein are applied and
repeated for multiple time segments, each at a predetermined stimulation (repetition) ncy.
The four subroutines may be repeated, such as with each segment of the four subroutines lasting
120 seconds, for example. As described above, tactile stimulus may be provided concurrently
with the auditory stimulus. The light may be provided at a wavelength of 580 nm and the
auditory having a frequency of 432 Hz may be provided.
Table 2 below bes an exemplary treatment regimen for this example. The
stimulation provided in Table 2 cycles through a block of four Segment A outputs 10 times. For
Segment A1, A2, A3, and A4, the ry and light s cycle 115 or 116 times between
being on for 0.1277 seconds and then being off for 0.1277 seconds, followed by no output for 0.5
seconds. Segments A1 pulses the right and left sides of both the light and auditory together, with
all outputs are synchronized to be on or off at the same time, as provided by subroutine 450a.
Segment A2 onizes the left side light and auditory output, and the right side light and
auditory output to be te to one another, as provided by subroutine 450b. Segment A3
synchronizes both lights together to be opposite to both auditory s, as provided by
subroutine 450C. Segment A4 onizes the right auditory and light to be opposite to the left
auditory and light outputs, as provided by subroutine 450d.
TABLE 2
Repeat the following Segments
A1-A4 10 times for a total time
of 20 minutes
Segment A1 (Light and Auditory On 0.1277s On 0.1277s On 0.1277s On s
both sides pulse together)
Repeat 116 times, ed by 05 Off 0.1277s Off0.1277s Off 0.12775 Off 0.1277s
sec gap
Segment A2 (light and auditory
on left side, alternating light and On s Off 0. 12775 On 0.12775 Off 0. 1277s
auditory on Right)
Repeat 116umes= fouowed by 0'5 Off 012775 On 0.12775 Off 0. 12775 On 0.12775
together, alternating With both On 0.12775 On 0.12775 Off 0. 12775 Off 0.12775
auditories together)
light right er, alternating On 5 Off0. 12775 Off 0. 12775 On 0.12775
auditory right and light left
together)
sec gap
EXAMPLE 4
The following described yet another example of a ation pattern that has been
found by empirical studies to be effective for increasing energy levels in the t. Light and
auditory stimulus at a first frequency may be provided for a first time segment, then at a second
higher frequency for a second time segment, then back at the first frequency for a subsequent
time segment, and so forth. Each time segment may include one or more sub—segments of light
and auditory stimulus, each sub-segment comprising one of the tines bed above, for
example. The light and auditory stimulus may end after a pre-determined time , such as 20
minutes. As described above, tactile stimulus may be provided concurrently with the auditory
us. The light may be provided at a wavelength of 580 nm and the auditory having a
frequency of 432 Hz may be provided.
Table 3 below describes an exemplary treatment regimen for this example. The
stimulation provided in Table 3 cycles ten times first through a block of four Segment A outputs,
then through a block of four Segment D outputs. For Segment A outputs (A1, A2, A3, and A4),
the auditory and light outputs cycle 115 or 116 times n being on for 0.1277 seconds and
then being off for 0.1277 seconds, followed by no output for 0.5 seconds. For Segment D outputs
(D1, D2, D3 and D4), the auditory and light outputs cycle 44 or 45 times between being on for
0.0667 seconds and then being off for 0. 0667 seconds, followed by no output for 0.5 seconds.
Segments A1 and D1 pulse the right and left sides of both the light and auditory together, with all
outputs are synchronized to be on or off at the same time, as provided by subroutine 450a.
Segments A2 and D2 synchronize the left side light and auditory output, and the right side light
and auditory output to be opposite to one another, as ed by subroutine 450b. Segments A3
and D3 synchronize both lights together to be te to both auditory outputs, as provided by
subroutine 450e, Segments A4 and D4 synchronize the right auditory and light to be opposite to
the left ry and light outputs, as provided by subroutine 450d.
TABLE 3
—fggltory Auditory Right Light Left Light Right
Repeat 10 times: Segments
A1-A4 followed by Segments
Segment A1 (Light and
Auditory both sides pulse
0.5 sec gap
auditory on left side, On 0.12775 Off 5 On 0.12775 Off 0.12775
alternating light and auditory
Repeat 116 times, followed by Off 5 On 0.12775 Off 0.1277s On 0.12775
together, alternating with both On 0.1277s On 0.1277s Off 0.1277s OffO. 1277s
auditories together)
light right er, alternating On 0.1277s Off 0.1277s Off 0.12775 On 0.1277s
auditory right and light left
Repeat 115 times, followed by Off 0.12775 On 0.12775 On 0.12775 OffO. 12775
0.5 sec gap
Segment D1 (Light and On 0.0667s On 0.0667s On 006675 On 0.0667s
Auditory both sides pulse
together)
Off 0.0667s Off 0.0667s Off 0,0667s Off 0.0667s
Repeat 221 times, ed by
Segment D2 (light and
auditory on left side, On 0.0667s Off 0.0667s On 0.06675 Off 0.0667s
alternating light and auditory
on Right)
Repeat 221 times, followed by Off 0.06675 On 0.0667s Off s On 5
Segment D3 ( both lights
together, alternating with both On 0.06675 On 0.06675 Off 0.0667s Off 0.06675
auditories together)
Repeat 221 “mes’ fouowed by Off 0.06675 Off 0.0667s On 0.0667s On 0.06675
WO 91758
Segment D4 (auditory left and
light right together, alternating On 0.0667s Off 0.0667s Off 006673 On 0.0667s
auditory right and light left
together)
Repeat 221 times, followed by Off 006675 On 0.0667s On 0.0667s Off 0.0667s
EXAMPLE 5
The following Table 4 lists experimental results for the use of the inventive methods.
The table lists what was being tested or treated, details of the conditions, the number of subjects,
and the results of the tests. In each case, the stimulation in Example 1 for treating eep
related problems and for inducing a short sleep, and the stimulation in Example 2 was used for all
other treatments.
Several of the treatments provided improvements in al and/or mental
performance, such as improving fine motor l and reaction times. This may be due to the
device ing improved neuroplasticity in the days after treatment. Other treatments provided
improvements in ming tasks and recovery from brain injury, such as injuries resulting from
oxygen deprivation (strokes) and for those suffering from traumatic brain injury (TBI) or mild
traumatic brain , and my provide improving balance, improving fine motor control. Other
treatments provided relief to sufferers of PTSD by reducing the subj ect’s response to triggering
stimuli.
TABLE 4
Reduction of chronic nerve
damage pain and improvement
Pain
of sleep on self. Use of device
Management for 3 months with 20 min/day of
ISigniflcant improvements in
marksmanship1n all participants and
ease of concentration during speed
driving, faster times on endurance
rials for 19/20 subjects
W0 2017l091758
Improved performance of fine motor
skills on surgical procedures VR
simulation for all subjects.
% and 30% respectively
increased speed in stripping and
reassembling s. (average
each of 5 tests, pre and post
raining) 6% average
improvement in marksmanship
scores - highly significant for
such level of skill for all sub'ects
% e improvement in .
Total absence of any PTSD
1 L&S stimulation and biofeedback.
Group 2 - just L&S stimulation
Brain State
Group 3 just biofeedback, Group 4
control. Double blinded - those
administering had no idea of what
was oredicted to ha oen
Dramatic ements in half of
subjects. Small improvements in
remaining half of subjects
Successful in 31/33 subjects
Driver performance using VR Immediate increase in reaction
simulators for on speeds and speeds and improved
uerformance under stress performance for all subjects
-25% increase in speeds to complete
performance. Trained for 4 hours,
Batte of 21 tests
All subjects fell asleep using the device
during training, including one subject
hat was ill with a virus and couldn't
Subject won his first Grand Prix of the
Subject went from 5th ranked to
l ihest ranked
Observable balance improvement in
Use on 6 year post stroke subjects. 7/10 subjects. 3 SUbl ectshad had
four hours training. dramatic improvements in their
Effect on seizures of ensitive reduction in both severity and
epileptics. 4 hours ng, ,
frequency of es, for at least a
oeriod of at least one month,
Concuss10n All subjects appeared to have recovery
Effect on concussions 18
Recove | an oen at ve fast 5 eed.
Performance Effect on mus1cal ability of a Jazz 1 Greatly improved performance speed
ement mus1c1an.
19 individuals saw a cessation of
major ms - flashbacks,
| ightmares, cold sweats and
PTSD. Treatment protocol lasting 3
22 l ypervigilance. the remaining 3
sessions of 2 hours each
appeared to be calmer after treatment,
but did not stop the major neurological
s mtoms
_—-Goestos1ee4timesm45 mins
Subject had constant pain on touching
arms with no relief in 3 years Subject
saw immediate pain relief on first use
Pain of the device. ued use over the
Chronic Regional Pam me. . .
Management following weeks results in periods of
ime without pain grow up to four
I ours following each use. Averaging at
After six months of use, the subject
continues getting 30% more sleep, and
a significant reduction in pain. Device
continues to be used 3-4 times a week
for 20 min.
While preferred embodiments of the present invention have been shown and
described herein, it will be obvious to those skilled in the art that such embodiments are provided
by way of example only, us variations, changes, and substitutions will now occur to
those skilled in the art without departing from the invention. It should be understood that various
atives to the embodiments of the invention bed herein may be employed in practicing
the invention. It is intended that the following claims define the scope of the invention and that
methods and structures within the scope of these claims and their equivalents be covered thereby
It is to be understood that the invention includes all of the different combinations
embodied herein. Throughout this specification, the term “comprising” shall be synonymous with
“including,77 cccontaining,” or “characterized by,” is inclusive or open-ended and does not exclude
additional, unrecited elements or method steps. “Comprising” is a term of art which means that
the named ts are essential, but other elements may be added and still form a construct
within the scope of the ent. “Comprising” leaves open for the inclusion of unspecified
ingredients even in major amounts.
Claims (31)
1. A non-therapeutic method of providing sensory stimulation to a user, the method comprising: alternating sensory stimulation between a first sensory stimulation ing simultaneously providing a left visual stimulus pattern to a left eye of the user and a right auditory stimulus pattern to the right side of the head; and a second sensory stimulation including simultaneously providing a right visual stimulus pattern to a right eye of the user and a left auditory stimulus pattern to the left side of the head of the user, wherein one or more of the left auditory stimulus pattern or the right auditory stimulus pattern comprises a sequence of stimulus patterns including a first stimulus pattern having a first pulse ncy between 3.75 Hz and 4.25 Hz, a second stimulus pattern having a second pulse frequency between 1.25 Hz and 1.75 Hz, and a third stimulus pattern having a third pulse frequency n 0.25 Hz and 0.75 Hz.
2. The method of claim 1, further comprising: periodically ing a sensory stimulation including simultaneously providing a left visual stimulus pattern to the left eye of the user, a right visual stimulus n to the right eye of the user, a left auditory stimulus pattern to the left side of the head, and a right auditory stimulus n to the right side of the head of the user.
3. The method of claim 2, further sing: ating sensory stimulation between a third sensory stimulation including simultaneously providing a left visual stimulus pattern to the left eye of the user and a left auditory stimulus pattern to the left side of the head, and a fourth sensory stimulation including aneously ing a right visual stimulus pattern to the right eye of the user and a right auditory stimulus pattern to the right side of the head of the user.
4. The method of claim 3, further comprising: alternating sensory stimulation between a fifth sensory stimulation ing simultaneously providing a left auditory stimulus pattern to the left side of the head and a right auditory stimulus pattern to the right side of the head, and a sixth sensory stimulation including aneously providing a left visual stimulus pattern to the left eye of the user and a right visual stimulus pattern to the right eye of the user.
5. The method of claim 1, n the left auditory us pattern comprises generating the left auditory stimulus pattern with a left speaker, and wherein generating the right auditory stimulus pattern comprises generating the right auditory stimulus pattern with a right speaker.
6. The method of claim 1, wherein the left auditory stimulus pattern comprises generating the left ry stimulus pattern with a left bone conduction transducer of a headset, and wherein the right auditory stimulus pattern comprises generating the right auditory stimulus pattern with a right bone conduction transducer of the headset.
7. The method of claim 1, wherein one or more of the left or right auditory us pattern includes an auditory frequency of from 240 Hz to 480 Hz.
8. The method of claim 1, wherein one or more of the left visual stimulus pattern or right visual stimulus pattern comprises repeatedly g a light at one or more of a first frequency, a second frequency less than the first frequency, or a third frequency less than the first and second frequencies.
9. The method of claim 8, wherein the first frequency is between 3.75 Hz and 4.25 Hz, the second ncy is between 1.25 Hz and 1.75 Hz, and the third frequency is between 0.25 Hz and 0.75 Hz.
10. The method of claim 9, wherein repeatedly pulsing the light comprises pulsing the light for a predetermined time interval.
11. The method of claim 10, wherein the predetermined time al is 25-45
12. The method of claim 1, wherein the sequence of us patterns each have a pulse frequency having a pulse period, where a portion of the pulse period includes a stimulus of an auditory frequency of from 240 Hz to 480 Hz.
13. The method of claim 12, wherein said n of said pulse period is one half of the pulse period.
14. The method of claim 1, wherein said first stimulus pattern, said second stimulus pattern, or said third us n ates for a predetermined time interval.
15. The method of claim 14, wherein the predetermined time interval is 25-35 seconds.
16. The method of claim 15, wherein the predetermined time interval is 30 seconds.
17. A non-therapeutic method of providing performance enhancement using the method of Claim 1.
18. The method of claim 17, where said performance enhancement is ing sleep, the improvement of mental capabilities, or the improvement of physical capabilities, for non-therapeutic purposes.
19. An apparatus to provide stimulation to a user, the apparatus comprising: a frame configured to be worn on a head of the user; a controller programmed to generate a plurality of inputs including a left light source input, a right light source input, a left auditory source input, and a right auditory source input; a left light source configured to generate a left visual stimulus pattern from said left light source input; a right light source configured to generate a right visual stimulus pattern from said right light source input; a left auditory source configured to generate a left auditory stimulus pattern from said left auditory source input; and a right auditory source configured to generate a right auditory stimulus pattern from said right auditory source input; where said ller is programmed to generate inputs which alternate between a first input including simultaneously ting the left light source input and the right auditory source input, and a second input including simultaneously generating the right light source input and the left auditory source input, wherein one or more of the left auditory source input or the right auditory source input comprises a sequence of a stimulus patterns including a first stimulus pattern having a first pulse ncy between 3.75 Hz and 4.25 Hz, a second us pattern having a second pulse frequency between 1.25 Hz and 1.75 Hz, and a third stimulus pattern having a third pulse frequency between 0.25 Hz and 0.75 Hz.
20. The apparatus of claim 19, wherein one or more of the left auditory source or the right auditory source is a speaker.
21. The apparatus of claim 19, n one or more of the left auditory source or the right auditory source is a bone conduction transducer.
22. The tus of claim 19, wherein one or more of the left or right light source comprises a light-emitting diode (LED).
23. The apparatus of claim 22, wherein one or more of the left or right light source is configured to generate light at 550-610 nm.
24. The apparatus of claim 22, wherein one or more of the left or right light source is configured to generate light at 580 nm.
25. A non-therapeutic method of providing performance enhancement ing the apparatus as claimed in any one of claims 19 - 24, said method comprising: providing a headset to be worn by a user; providing a sensory stimulation to the user from the headset, where said stimulation alternates between a first sensory stimulation ing simultaneously providing a left visual stimulus n to a left eye of the user and a right auditory stimulus pattern to the right side of the head, and a second sensory stimulation including aneously providing a right visual stimulus pattern to a right eye of the user and a left auditory stimulus pattern to the left side of the head of the user, wherein one or more of the left auditory stimulus pattern or the right auditory stimulus pattern comprises a sequence of stimulus patterns ing a first stimulus pattern having a first pulse frequency between 3.75 Hz and 4.25 Hz, a second stimulus pattern having a second pulse frequency n 1.25 Hz and 1.75 Hz, and a third stimulus pattern having a third pulse frequency between 0.25 Hz and 0.75 Hz.
26. The method of claim 25, where said performance enhancement is providing sleep, the improvement of mental capabilities, or the improvement of physical capabilities, for non-therapeutic purposes.
27. The apparatus according to any one of claims 19 – 24, wherein the apparatus is ured to provide a first sensory stimulation including simultaneously providing a left visual us pattern to a left eye of the user and a right auditory us pattern to the right side of the head, and a second sensory stimulation including simultaneously providing a right visual stimulus pattern to a right eye of the user and a left auditory stimulus pattern to the left side of the head of the user.
28. The tus according to claim 27, wherein the apparatus is capable of providing performance enhancement, including providing sleep, improvement of mental capabilities, and/or improvement of physical capabilities.
29. The apparatus according to any one of claims 19 – 24, wherein the apparatus is configured to treat, or is capable of treating, a neurological disease or condition.
30. The apparatus of claim 29, wherein the neurological e or condition is selected from the group comprising insomnia, PTSD or brain .
31. The apparatus of claim 29, wherein the apparatus is configured to increase, or is capable of sing, alpha wave activity in the brain.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562258965P | 2015-11-23 | 2015-11-23 | |
US62/258,965 | 2015-11-23 | ||
PCT/US2016/063651 WO2017091758A1 (en) | 2015-11-23 | 2016-11-23 | Methods and systems for providing stimuli to the brain |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ743587A NZ743587A (en) | 2021-03-26 |
NZ743587B2 true NZ743587B2 (en) | 2021-06-29 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020264336B2 (en) | Methods and systems for providing stimuli to the brain | |
US10799667B2 (en) | Methods and systems for modulating stimuli to the brain with biosensors | |
US10328235B2 (en) | System and method for the treatment of insomnia | |
JP5491676B2 (en) | Apparatus and method for non-invasive stimulation that results in desynchronization using conditioning | |
US10722678B2 (en) | Device and method for effective non-invasive two-stage neurostimulation | |
ES2758365T3 (en) | Device for non-invasive neurostimulation by means of multichannel bursts | |
KR20160018660A (en) | Transcranial pulsed current stimulation | |
NZ743587B2 (en) | Methods and systems for providing stimuli to the brain | |
RU2266144C2 (en) | Device for measuring cerebral activity level by emitting sensory irritants | |
US20230347103A1 (en) | Methods and systems for providing sensory stimulation to a brain to treat post-traumatic stress disorder | |
US11536965B2 (en) | Technologies for multi-randomized audio-visual entrainment | |
EA039956B1 (en) | METHOD AND SYSTEM FOR CONTROLLING BRAIN STIMULATION USING BIO SENSORS |